Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)

被引：0
|
作者：
Andrea Camerini
Cheti Puccetti
Sara Donati
Chiara Valsuani
Maria Cristina Petrella
Gianna Tartarelli
Paolo Puccinelli
Domenico Amoroso
机构：
[1] Versilia Hospital and Istituto Toscano Tumori,Medical Oncology
来源：
BMC Cancer | / 15卷
关键词：
Elderly; Non-small-cell lung cancer; Metronomic vinorelbine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Docetaxel (Taxotere) and vinorelbine in the treatment of advanced non-small cell lung cancer: Preliminary results of a phase I/II trial
    Miller, VA
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : S15 - S17
  • [32] Phase II trial of satraplatin (S) and paclitaxel (P) in first-line advanced non-small cell lung cancer (NSCLC) treatment: Final results
    Thompson, D. S.
    Spigel, D. R.
    Hainsworth, J. D.
    Jones, S. F.
    Burris, H. A., III
    Sade, L.
    Raefsky, E.
    Greco, F. A.
    Yun, S.
    Noursalehi, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [33] Oral vinorelbine in elderly patients with advanced non-small cell lung cancer
    Spasova, I.
    Davidova, R.
    Csemyova, S.
    Musil, J.
    LUNG CANCER, 2006, 52 : S41 - S42
  • [34] Oral Metronomic Vinorelbine in Advanced Non-small Cell Lung Cancer Patients Unfit for Chemotherapy
    Banna, Giuseppe L.
    Camerini, Andrea
    Bronte, Giuseppe
    Anile, Giuseppe
    Addeo, Alfredo
    Rundo, Francesco
    Zanghi, Guido
    Lal, Rohit
    Libra, Massimo
    ANTICANCER RESEARCH, 2018, 38 (06) : 3689 - 3697
  • [35] Results of a Phase I/II Trial of Amrubicin (AMR) in Combination with Cisplatin (CDDP) as First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
    Hattori, Yoshihiro
    Yamamoto, Nobuyuki
    Ichinose, Yukito
    Negoro, Shunichi
    Hida, Toyoaki
    Takeda, Koji
    Masuda, Noriyuki
    Nakagawa, Kazuhiko
    Yokota, Soichiro
    Fukuoka, Masahiro
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S386 - S386
  • [36] Results of a phase I/II trial of amrubicin (AMR) in combination with cisplatin (CDDP) as a first-line treatment in patients with advanced non-small cell lung cancer (NSCLC)
    Seto, T.
    Ichinose, Y.
    Yamamoto, N.
    Kaira, K.
    Negoro, S.
    Hida, T.
    Takeda, K.
    Masuda, N.
    Yokota, S.
    Fukuoka, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer
    Elisabetta Campagnoli
    Isabella Garassino
    Armando Santoro
    Fabio De Vincenzo
    Paolo Andrea Zucali
    Giovanni Luca Ceresoli
    Fabio Romano Lutman
    Marco Alloisio
    Hector Josè Soto Parra
    Raffaele Cavina
    Investigational New Drugs, 2007, 25 : 559 - 564
  • [38] Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer
    Campagnoli, Elisabetta
    Garassino, Isabella
    Santoro, Armando
    De Vincenzo, Fabio
    Zucali, Paolo Andrea
    Ceresoli, Giovanni Luca
    Lutman, Fabio Romano
    Alloisio, Marco
    Parra, Hector Jose Soto
    Cavina, Raffaele
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (06) : 559 - 564
  • [39] Phase II study of biweekly carboplatin and paclitaxel as first-line treatment for elderly patients with advanced non-small cell lung cancer
    Terai, H.
    Soejima, K.
    Nakamura, M.
    Naoki, K.
    Yasuda, H.
    Satomi, R.
    Nakayama, S.
    Yoda, S.
    Ikemura, S.
    Sato, T.
    Asano, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] A phase I trial of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer
    Govindan, R
    Lim, WT
    Arquette, MA
    Goodner, SA
    Fears, CL
    Mortimer, JE
    Fracasso, PM
    ONCOLOGY REPORTS, 2006, 15 (01) : 123 - 127
12345